Skip to main content
Journal cover image

Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study.

Publication ,  Journal Article
Evans, DR; Lazarides, AL; Cullen, MM; Somarelli, JA; Blazer, DG; Visguass, JD; Brigman, BE; Eward, WC
Published in: Ann Surg Oncol
February 2022

BACKGROUND: Limited data are available to inform the risk of readmission and short-term mortality in musculoskeletal oncology. The goal of this study was to identify factors independently associated with 30-day readmission and 90-day mortality following surgical resection of chondrosarcoma. METHODS: We retrospectively reviewed 6653 patients following surgical resection of primary chondrosarcoma in the National Cancer Database (2004-2017). Both demographic and clinicopathologic variables were assessed for correlation with readmission and short-term mortality utilizing univariate and multivariate logistic regression modeling. RESULTS: Of 220 readmissions (3.26%), risk factors independently associated with an increased risk of unplanned 30-day readmission included Charlson-Deyo Comorbidity Index (CDCC) (odds ratio [OR] 1.31; p = 0.027), increasing American Joint Committee on Cancer (AJCC) stage (OR 1.31; p = 0.004), undergoing major amputation (OR 2.38; p = 0.001), and axial skeletal location (OR 1.51; p = 0.028). A total of 137 patients died within 90 days of surgery (2.25%). Risk factors associated with increased mortality included the CDCC (OR 1.60; p = 0.001), increasing age (OR 1.06; p < 0.001), having Medicaid insurance status (OR 3.453; p = 0.005), living in a zip code with a higher educational attainment (OR 1.59; p = 0.003), increasing AJCC stage (OR 2.32; p < 0.001), longer postoperative length of stay (OR 1.015; p = 0.033), and positive surgical margins (OR 2.75; p = 0.001). Although a majority of the cohort did not receive radiation therapy (88.8%), receiving radiotherapy (OR 0.132; p = 0.010) was associated with a decreased risk of short-term mortality. CONCLUSIONS: Several tumor, treatment, and patient factors can help inform the risk of readmission and short-term mortality in patients with surgically treated chondrosarcoma.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

February 2022

Volume

29

Issue

2

Start / End Page

1392 / 1408

Location

United States

Related Subject Headings

  • United States
  • Risk Factors
  • Retrospective Studies
  • Postoperative Complications
  • Patient Readmission
  • Oncology & Carcinogenesis
  • Humans
  • Chondrosarcoma
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Evans, D. R., Lazarides, A. L., Cullen, M. M., Somarelli, J. A., Blazer, D. G., Visguass, J. D., … Eward, W. C. (2022). Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study. Ann Surg Oncol, 29(2), 1392–1408. https://doi.org/10.1245/s10434-021-10802-8
Evans, Daniel R., Alexander L. Lazarides, Mark M. Cullen, Jason A. Somarelli, Dan G. Blazer, Julia D. Visguass, Brian E. Brigman, and William C. Eward. “Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study.Ann Surg Oncol 29, no. 2 (February 2022): 1392–1408. https://doi.org/10.1245/s10434-021-10802-8.
Evans DR, Lazarides AL, Cullen MM, Somarelli JA, Blazer DG, Visguass JD, et al. Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study. Ann Surg Oncol. 2022 Feb;29(2):1392–408.
Evans, Daniel R., et al. “Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study.Ann Surg Oncol, vol. 29, no. 2, Feb. 2022, pp. 1392–408. Pubmed, doi:10.1245/s10434-021-10802-8.
Evans DR, Lazarides AL, Cullen MM, Somarelli JA, Blazer DG, Visguass JD, Brigman BE, Eward WC. Identifying Modifiable and Non-modifiable Risk Factors of Readmission and Short-Term Mortality in Chondrosarcoma: A National Cancer Database Study. Ann Surg Oncol. 2022 Feb;29(2):1392–1408.
Journal cover image

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

February 2022

Volume

29

Issue

2

Start / End Page

1392 / 1408

Location

United States

Related Subject Headings

  • United States
  • Risk Factors
  • Retrospective Studies
  • Postoperative Complications
  • Patient Readmission
  • Oncology & Carcinogenesis
  • Humans
  • Chondrosarcoma
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis